Abstract
Serum gastrin levels in 44 peptic ulcer patients (26 gastric ulcer patients and 18 duodenal ulcer patients) were determined after they had been treated with omeprazole (OPZ) (20 mg/day) alone or in combination with pirenzepine (PZP) (100 mg/day). Serum gastrin levels were measured before, as well as 2, 4 and 6 weeks after administration, and the changes were compared. The levels were significantly elevated (twofold) at 2 weeks of treatment in both the OPZ and OPZ plus PZP groups. In patients taking OPZ alone, the levels rose up to 6 weeks, while in those taking OPZ plus PZP the levels decreased at 4 and 6 weeks. At 4 weeks, serum gastrin levels in the OPZ plus PZP group were lower (although not significantly) than those in patients taking OPZ alone. In gastric ulcer patients, serum gastrin levels in the OPZ group were significantly elevated, while in the OPZ plus PZP group, these levels were only slightly, but not significantly elevated. There was no significant difference between the two gastric ulcer groups at any time. In duodenal ulcer patients, serum gastrin levels increased significantly at 2 weeks of treatment in both groups. At 4 weeks and thereafter, the serum gastrin levels remained significantly high in patients taking OPZ alone, while they decreased at both 4 and 6 weeks in patients taking OPZ plus PZP. Thus, serum gastrin levels in duodenal ulcer patients were markedly decreased by the addition of PZP. These results demonstrate that PZP inhibits the increase in serum gastrin levels induced by OPZ, and suggest that PZP may suppress the rebound hyperacidity that occurs after treatment with OPZ, thus preventing ulcer recurrence.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Matsuo Y, Seki A, Effect of pirenzepine (LS-519) on gastric secretion and motility and on experimental gastric ulcer (in Japanese). Kiso-to-Rinsho (Clin Report) 1977;11:897–909.
Sakai Y, Iwasaki A, Matsuo Y. Effect of an H+, K+-ATPase inhibitor (omeprazole) aone or in combination with other agents on gastrointestinal hormones in the gastric mucosa of rats (in Japanese). I-Bunpitsu Kenkyukaishi 1991;23:81–84.
Festen HPM, Thijs JL, Lamers HW, et al. Effect of oral omeprazole on serum gastrin and serum pepsinogen I levels. Gastroenterology 1984;87:1030–1034.
Howden CW, Reid JL, Forrest JAH. Effect of omeprazole on gastric secretion in human volunteers (abstract). Gut 1983; 24:A498.
Sharma BK. Optimal dose of oral omeprazole for maximum 24-hour decrease of intragastric acidity. Gut 1984;25:957–964.
Muller P. Human acid secretion during and after 18 days' treatment with omeprazole. Ital J Gastroenterol 1985;17:96–97.
Cederberg C, Ekenved G, Lind T, et al. Acid inhibitory characteris of omeprazole in man. Scand J Gastroenterol 1985; 20(Suppl 108):105–112.
Londong W, Londong V, Cederberg C, et al. Dose-response study of omeprazole on meal-stimulated gastric acid secretion and gastrin release. Gastroenterology 1983;85:1373–1378.
Konturek SJ, Kweicien N, Obtulowicz W, et al. Action of omeprazole (a benzimadazole derivative) on secretory responses to sham feeding and pentagastrin and upon serum gastrin and pancreatic polypeptide in duodenal ulcer patients. Gut 1984; 25:14–18.
Allen JM, Bishop AE, Daly MJ, et al. Effect of inhibition of acid secretion on the regulatory peptides in the rat stomach. Gastroenterology 1986;90:970–977.
Tatsuta M, Mishima T, Baba M, et al. Therapeutic effect of pirenzepine (LS-519) on refractory gastric ulcer and its effect on serum gastrin (in Japanese) Jpn J Clin Exp Med 1980;57:3103–3111.
Konturek SJ, Obtulowicz W, Kwiecien N, et al. Effect of pirenzepine and atropine on gastric secretory and plasma hormonal responses to sham feeding in patients with duodenal ulcer. Scand J Gastroenterol 1980;15:63–69.
Sekido T. Effects of atropine and pirenzepine on gastrin and somatostatin secretion under electrical stimulation of the vagus nerve (in Japanese). Nihon Univ J Med 1988;47:1081–1086.
Lehy T, Gres L, Bronfils S. Effect of prolonged pirenzepine administration on the gastric cell populations in the rat. Gastroenterol Clin Biol 1978;2:1001–1009.
Tabata S, Okabe S. Gastric secretory conditions and plasma gastric levels in rats after prolonged treatment with cimetidine. Dig Dis Sci 1984;29:4–45.
Umezawa M. Effects of long-term H2-receptor antagonist administration on antral G-cells, serum gastrin concentrations, and gastric acid secretion—an experimental and clinical study (in Japanese). Tokyo Jikeikai Med J 1987;102:531–542.
Sundler F, Hakason R, Carlsson E, et al. Hypergastrinemia after blockade of acid secretion in the rat. Trophic effects. Digestion 1986;35(Suppl 1):56–69.
Morita R, Harasawa S, Miwa T, et al. Effect of long-term administration of antisecretory drugs on rat gastric histamine synthesis and acid secretion. Comparison of omeprazole and cimetidine (in Japanese). Jpn J Gastroenterol 1992;89: 2551–2558.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Iwasaki, A., Miyazawa, K., Kawamura, Y. et al. Serum gastrin levels following administration of omeprazole alone or in combination with pirenzepine. J Gastroenterol 29, 398–402 (1994). https://doi.org/10.1007/BF02361234
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02361234